bpc 157 ulcerative colitis trials Pentadecapeptide 157, in clinical as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system Left, 14 days) (right, 28

(dated September 30) indicating that some of its PROLAB protein powders are being recalled as they may contain undeclared milk, wheat and gluten allergens

NI Peptides does not market this product as a medicine or for any form of human or veterinary application

BPC-157 is a synthetic peptide derived from a protein found in the stomach, best known in repair research for healing tissue and tendons, protecting the gut, and supporting recovery

WADA Status: According to the World Anti-Doping Agency (WADA), all non-approved substances fall under the S0 category (Non-Approved Substances) and are prohibited in sport at all times even if they are not specifically named on the prohibited list